BriaCell Therapeutics Corp. - stock earnings
BCTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -4.9 million USD | ? USD |
| 2023Q1 | -11.9 million USD | ? USD |
| 2022Q4 | -1.1 million USD | ? USD |
| 2022Q3 | -15.7 million USD | ? USD |
| 2022Q2 | -4.8 million USD | ? USD |
| 2022Q1 | -3.9 million USD | ? USD |
| 2021Q4 | -2.4 million USD | ? USD |
| 2021Q3 | -2.7 million USD | ? USD |
| 2021Q2 | 3.6 million USD | ? USD |
BCTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -20.3 million USD | ? USD |
| 2022 | -11.6 million USD | ? USD |
| 2021 | -2.9 million USD | ? USD |
| 2020 | 1.4 million USD | ? USD |
| 2019 | 602680 USD | ? USD |
| 2018 | 1.1 million USD | ? USD |
| 2017 | -2.6 million USD | ? USD |
| 2016 | -1.7 million USD | ? USD |
| 2015 | -2.7 million USD | ? USD |
| 2014 | -8.1 million USD | ? USD |
| 2013 | -368694 USD | ? USD |
| 2012 | -995723 USD | ? USD |
| 2011 | -1.1 million USD | ? USD |
| 2010 | -900738 USD | ? USD |
| 2009 | -228812 USD | ? USD |
| 2008 | -98926 USD | ? USD |
| 2007 | -116406 USD | ? USD |
| 2006 | -8580 USD | ? USD |
BCTX
Price: $2.11
52 week price:
Earnings Per Share: -0.79 USD
P/E Ratio: -2.27
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 135600
Market Capitalization: 44.6 million